Semaglutide Clinics in Connecticut
Compare Semaglutide providers in Connecticut. Check ratings, telehealth availability, and insurance acceptance to find the right prescriber.
Cities With Semaglutide Providers in Connecticut
All Semaglutide Clinics in Connecticut
NutriGreene
Superior Health & Wellness Clinic
Medi-Weightloss West Hartford
Pounds Medical Weight Loss Transformation
CT Medical Weight Loss and Beyond
WeightWorx Medical Weight Loss
Gameday Men's Health West Hartford
Pavlos K. Papasavas, MD
Devika Umashanker, MD
FemCare MedSpa
Awaken180° Weightloss
Medi-Weightloss Wethersfield
Restore Hyper Wellness
Medical Weight Loss Solutions
Everest Diabetes & Weight Loss
Vitality Weight and Hormone Solutions
Medi-Weightloss Orange
Revolutionary Wellness and Weight Loss
HyperFit MD Age Management Center
Medi-Weightloss Oxford
Yale Health Center
Renew Medical CT
Yale Medicine Bariatric and Minimally Invasive Surgery
Glow Medical Aesthetics
Charli Blake's Med Spa
The RadianceMD
Medi-Weightloss Wallingford
Connecticut Medical Weight Loss Doctors
Medi-Weightloss Stamford
Restore Hyper Wellness
Dr. Henry C. Sobo, MD
New York Bariatric Group
Greenwich MD
Ultimate Solutions Medical Spa
NutriGreene
CMWL - The Center For Medical Weight Loss Stamford
Haute Healing Oasis
Medi-Weightloss Wilton
PURE Medical Aesthetics
Medi-Weightloss Enfield
About Semaglutide in Connecticut
What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, which regulates appetite and blood sugar. Originally developed for type 2 diabetes (Ozempic), it was later approved at a higher dose for chronic weight management (Wegovy). Semaglutide has become the most recognized name in the GLP-1 weight loss category, with clinical trials showing average weight loss of 15-17% of body weight.
Brand Names
Semaglutide is available as Ozempic, Wegovy, Rybelsus, manufactured by Novo Nordisk.
Expected Weight Loss
In the STEP 1 trial, participants on Wegovy 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo. About one-third of participants lost 20% or more of their body weight.
Cost in Connecticut
Without insurance, Semaglutide typically costs $800-$1,200/month (Ozempic), $1,300-$1,400/month (Wegovy). With insurance, costs range from $25-$200/month (varies by plan). Compounded options may be available at $200-$500/month.
Savings programs: Novo Nordisk offers savings cards for eligible commercially insured patients. NovoCare patient assistance program available for uninsured/underinsured patients.
Frequently Asked Questions
There are 44 clinics prescribing Semaglutide (Ozempic and Wegovy and Rybelsus) in Connecticut. Connecticut is one of the better-served states for Semaglutide availability.
Yes, 32 of 44 Semaglutide providers in Connecticut (73%) offer telehealth. Most providers here support virtual visits, so you can start treatment without an office visit.
Brand-name Ozempic and Wegovy and Rybelsus costs $800–$1,400/month without insurance in Connecticut. Compounded Semaglutide from clinic weight loss programs typically runs $200–$500/month. With insurance, copays range from $25–$200/month depending on your plan's formulary and whether prior authorization is required.
Yes. Semaglutide is a prescription medication in all US states including Connecticut. You can get evaluated and prescribed through 32 telehealth providers in Connecticut, or visit any of the 44 clinics listed here in person.
Coverage depends on your plan and diagnosis. Semaglutide is widely covered for type 2 diabetes. For weight management, coverage is expanding — Wegovy and Zepbound now have broader approval, but many plans still require prior authorization or documented BMI criteria. Check with your insurer or ask the clinic to verify coverage before your appointment.
Related Articles
Ozempic vs Wegovy: What's the Difference?
Both contain semaglutide, but they're FDA-approved for different purposes. Here's what you need to know before choosing between them.
newsFDA Warning Letter to Novo Nordisk: What Ozempic and Wegovy Patients Should Know
The FDA issued a warning letter to Novo Nordisk over unreported potential side effects. Here is what it actually means for patients taking Ozempic or Wegovy.
weight-lossSemaglutide Weight Loss Results: What to Expect Month by Month
A realistic timeline of semaglutide weight loss results based on clinical trials and real-world data — from the first week through month 12 and beyond.